







he US XOS market is experiencing rapid growth, driven by increasing consumer awareness of gut health, growing demand for natural prebiotic ingredients, and expanding applications in functional foods and dietary supplements. In 2023, total production reached 2,500 metric tons, with the functional food sector accounting for 65% of market value. The market saw a 25% increase in demand for XOS in dairy products in 2023, particularly in probiotic yogurts and drinks. Use in dietary supplements is growing at 15% annually
his growth is primarily driven by escalating environmental concerns, stringent plastic regulations, and shifting consumer preferences toward sustainable packaging solutions across food, beverage, and consumer goods sectors. USD 23.7 million USD 42.5 million 10.2% ,
Accelerating Market Adoption
The US XOS market is experiencing rapid growth, driven by increasing consumer awareness of gut health, growing demand for natural prebiotic ingredients, and expanding applications in functional foods and dietary supplements. In 2023, total production reached 2,500 metric tons, with the functional food sector accounting for 65% of market value. The market saw a 25% increase in demand for XOS in dairy products in 2023, particularly in probiotic yogurts and drinks. Use in dietary supplements is growing at 15% annually. The market is witnessing a trend towards synbiotic formulations, with a 30% year-over-year
DuPont and BENEO lead in technology and market share, while regional players dominate specific applications. Vertical integration increases as manufacturers secure sustainable feedstock supplies. Patent activity focuses on purification methods and synergistic probiotic combinations. Private equity shows growing interest in specialized prebiotic manufacturers. The market sees increasing partnerships between ingredient suppliers and food brands for co-branded product development.
Boron neutron capture therapy (BNCT) is emerging as a promising cancer treatment modality, particularly for difficult-to-treat tumors like glioblastoma. Japan has led clinical adoption with over 200 patients treated since 2020, while China and Europe are ramping up clinical trials. The precision targeting capability of boron-10, when irradiated with low-energy neutrons, minimizes damage to healthy tissues - a significant advantage over conventional radiotherapy. Pharmaceutical companies are investing in boron-containing drug development, with several boron-10 based compounds currently in Phase II/III trials for various oncology indications.
The United States dominates the North American XOS market, representing nearly 85% of regional revenue in 2024. Growth is fueled by increasing consumer awareness of gut health and functional ingredients, with demand growing at 10.2% CAGR through 2030. Regulatory support from FDA-approved health claims about prebiotic benefits strengthens market positioning Europe Germany, France and the UK account for over 65% of European XOS consumption, largely driven by stringent EU food safety standards and strong supplement markets. Market growth is constrained by competition from established prebiotics like FOS and GOS, though XOS gains traction in specialized medical nutrition applications. BENEO GmbH leads regional innovation with patented XOS extraction processes. The European market shows particular interest in sustainable sourcing, with agricultural byproducts like wheat bran emerging as preferred raw materials. Regulatory challenges persist regarding novel food approvals for certain XOS concentrations.
• AIDP, Inc.
• • DuPont Nutrition & Health
• • Stratum Nutrition
• • Parchem Fine & Specialty Chemicals
• • BENEO GmbH
• • NxTerra Specialty Ingredients
• • Nutralliance
These companies represent some of the major key players driving innovation and growth in the market, contributing significantly to global supply and competitive dynamics.
SAMPLE PDF BROCHURE
Founded in 2015, 24chemicalresearch is a trusted name in global chemical industry intelligence. We specialize in delivering high-quality market research reports, empowering over 30+ Fortune 500 clients with data-driven insights for strategic growth. Our team of experienced analysts delivers customized, reliable, and timely research backed by a rigorous methodology. From mining regulatory trends to forecasting market opportunities, our reports help companies navigate industry challenges, stay competitive, and grow confidently.
As a one-stop platform for the chemical sector, we offer:
• Deep specialization in chemical market analysis
• Customized reports tailored to your needs
• A robust portal with free samples, consulting, and competitive insights